EPO and renal cell carcinoma: To evaluate the function of Epo/EpoR pathway in RCC cells, we used RNA interference method to down-regulate EpoR expression in 786-0 cells and then observed the changes in growth, invasiveness, apoptosis, and sensitivity to the clinically used multi-kinases inhibitor Sunitinib.